| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK subunit alpha-1, Acetyl-CoA carboxylase kinase, ACACA kinase, Hydroxymethylglutaryl-CoA reductase kinase, HMGCR kinase, Tau-protein kinase PRKAA1, Prkaa1, Ampk1 |
| Entrez GeneID | 65248 |
| WB Predicted band size | 64.0kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | This Rat Prkaa1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 16-47 amino acids from the N-terminal region of rat Prkaa1. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于PRKAA1 (N-term)抗体的示例参考文献(注：以下为虚构示例，仅供参考)：
---
1. **"AMPK α1 Subunit Phosphorylation in Metabolic Stress"**
*Authors: Smith J, et al. (2020)*
**摘要**：本研究利用针对PRKAA1 N端的抗体，通过Western blot分析小鼠肝脏组织中AMPKα1的激活状态，揭示了其在能量胁迫下的磷酸化调控机制。
2. **"Role of PRKAA1 N-terminal Domain in Mitochondrial Function"**
*Authors: Lee H, et al. (2018)*
**摘要**：通过免疫荧光和共聚焦显微镜技术，使用N端特异性抗体定位PRKAA1在线粒体膜上的分布，探讨其结构与细胞能量代谢的关联。
3. **"Antibody Validation for AMPK Isoform-Specific Studies"**
*Authors: Brown K, et al. (2016)*
**摘要**：系统验证了PRKAA1 (N-term)抗体的特异性，证明其可区分AMPKα1与α2亚型，为下游信号通路研究提供可靠工具。
4. **"PRKAA1 in Cancer Metabolism: A Therapeutic Target"**
*Authors: Garcia R, et al. (2019)*
**摘要**：使用PRKAA1 N端抗体进行免疫组化分析，发现肿瘤组织中AMPKα1表达水平与化疗敏感性显著相关。
---
如需真实文献，建议在PubMed或Google Scholar检索关键词：**PRKAA1 antibody N-terminal**，并筛选涉及实验方法学、抗体应用或疾病机制的相关研究。
The R Prkaa1 (N-term) antibody is designed to target the N-terminal region of the protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), a critical component of the AMP-activated protein kinase (AMPK) complex. AMPK functions as a cellular energy sensor, regulating metabolic homeostasis by responding to changes in intracellular ATP levels. It activates catabolic pathways (e.g., glucose uptake, fatty acid oxidation) while inhibiting anabolic processes (e.g., lipid synthesis) under energy-deficient conditions.
PRKAA1. the α1 catalytic subunit, contains a conserved kinase domain in its N-terminal region, which is essential for AMPK’s enzymatic activity. Antibodies targeting this region, such as R Prkaa1 (N-term), are widely used to detect endogenous PRKAA1 expression levels, assess post-translational modifications (e.g., phosphorylation at Thr172 for activation), or study AMPK’s role in cellular signaling. These applications are vital in research areas like metabolic disorders (diabetes, obesity), cancer (AMPK modulates tumor metabolism), and neurodegenerative diseases.
The specificity of R Prkaa1 (N-term) antibody for the N-terminal domain helps distinguish PRKAA1 from its isoform PRKAA2 (α2 subunit), which shares high sequence homology but may have tissue-specific functions. Validated in techniques like Western blotting, immunohistochemistry, and immunoprecipitation, this antibody serves as a key tool for elucidating AMPK’s regulatory mechanisms and therapeutic potential. Its reliability in recognizing the native conformation of PRKAA1 makes it valuable for both basic research and preclinical studies targeting metabolic dysregulation.
×
